T cell responses in patients with COVID-19

Z Chen, E John Wherry - Nature Reviews Immunology, 2020 - nature.com
The role of T cells in the resolution or exacerbation of COVID-19, as well as their potential to
provide long-term protection from reinfection with SARS-CoV-2, remains debated …

Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19

AK Azkur, M Akdis, D Azkur, M Sokolowska… - Allergy, 2020 - Wiley Online Library
As a zoonotic disease that has already spread globally to several million human beings and
possibly to domestic and wild animals, eradication of coronavirus disease 2019 (COVID‐19) …

Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study

G Grasselli, T Tonetti, A Protti, T Langer… - The lancet Respiratory …, 2020 - thelancet.com
Background Patients with COVID-19 can develop acute respiratory distress syndrome
(ARDS), which is associated with high mortality. The aim of this study was to examine the …

Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19)

S Umakanthan, P Sahu, AV Ranade… - Postgraduate …, 2020 - academic.oup.com
Coronavirus has emerged as a global health threat due to its accelerated geographic
spread over the last two decades. This article reviews the current state of knowledge …

Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations

J Phua, L Weng, L Ling, M Egi, CM Lim… - The lancet respiratory …, 2020 - thelancet.com
Summary As coronavirus disease 2019 (COVID-19) spreads across the world, the intensive
care unit (ICU) community must prepare for the challenges associated with this pandemic …

Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey

SJ Tzotzos, B Fischer, H Fischer, M Zeitlinger - Critical Care, 2020 - Springer
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) appeared just over 7 months ago in Wuhan, China. Early …

Management of acute kidney injury in patients with COVID-19

C Ronco, T Reis, F Husain-Syed - The Lancet Respiratory Medicine, 2020 - thelancet.com
The outbreak of coronavirus disease 2019 (COVID-19) has rapidly evolved into a global
pandemic. Most patients with COVID-19 have mild symptoms, but about 5% develop severe …

Immunological and inflammatory profiles in mild and severe cases of COVID-19

JW Song, C Zhang, X Fan, FP Meng, Z Xu, P Xia… - Nature …, 2020 - nature.com
Abstract COVID-19 is associated with 5.1% mortality. Although the virological,
epidemiological, clinical, and management outcome features of COVID-19 patients have …

Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review

E Ortiz-Prado, K Simbaña-Rivera… - … and infectious disease, 2020 - Elsevier
Coronaviruses are an extensive family of viruses that can cause disease in both animals
and humans. The current classification of coronaviruses recognizes 39 species in 27 …

Treatment with convalescent plasma for COVID‐19 patients in Wuhan, China

M Ye, D Fu, Y Ren, F Wang, D Wang… - Journal of medical …, 2020 - Wiley Online Library
The discovery of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and the
outbreak of coronavirus disease 2019 (COVID‐19) are causing public health emergencies …